Financial Ratios | Wockhardt Ltd. | R Wadiwala Securities Pvt Ltd

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE567.90-6.9 (-1.2 %)
PREV CLOSE (Rs.) 574.80
OPEN PRICE (Rs.) 564.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 33717
TODAY'S LOW / HIGH (Rs.)560.70 583.65
52 WK LOW / HIGH (Rs.)165.2 630
NSE568.85-3.7 (-0.65 %)
PREV CLOSE( Rs. ) 572.55
OPEN PRICE (Rs.) 572.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 326914
TODAY'S LOW / HIGH(Rs.) 560.50 580.30
52 WK LOW / HIGH (Rs.)165 630

Financial Ratios

Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-38.82-16.9462.36-6.25-17.58
   CEPS(Rs)-25.69-2.22-4.277.17-12.31
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)231.81266.04304.36238.55238.75
   Tax Rate(%)0.4832.1247.7159.6730.18
Margin Ratios
   Core EBITDA Margin(%)2.365.81-1.363.44-1.08
   EBIT Margin(%)-7.54-2.18-6.88-2.33-5.09
   Pre Tax Margin(%)-14.60-8.01-12.25-12.03-12.52
   PAT Margin (%)-14.53-5.44-6.41-4.85-8.74
   Cash Profit Margin (%)-8.66-0.62-1.103.03-4.15
Performance Ratios
   ROA(%)-8.42-3.71-3.93-1.80-4.01
   ROE(%)-17.32-7.77-9.92-5.22-11.43
   ROCE(%)-5.88-1.96-5.50-1.11-2.87
   Asset Turnover(x)0.580.680.610.370.46
   Sales/Fixed Asset(x)0.730.880.750.440.60
   Working Capital/Sales(x)-2.81-6.73-5.52-2.59-72.76
Efficiency Ratios
   Fixed Capital/Sales(x)1.371.141.332.251.67
   Receivable days73.2565.2985.04161.49114.46
   Inventory Days60.9555.7659.6398.5485.73
   Payable days293.71232.91255.87263.19160.83
Valuation Parameters
   PER(x)0.000.006.120.000.00
   PCE(x)-5.99-118.71-89.3722.20-33.17
   Price/Book(x)0.660.991.360.721.86
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)1.501.632.441.712.20
   EV/Core EBITDA(x)17.8516.5295.6230.78-448.40
   EV/EBIT(x)-12.36-46.92-20.68-73.27-43.16
   EV/CE(x)0.560.690.890.631.03
   M Cap / Sales0.841.181.680.671.38
Growth Ratio
   Net Sales Growth(%)-17.9319.28-4.78-20.24-9.43
   Core EBITDA Growth(%)-29.87360.87-56.281004.01-114.30
   EBIT Growth(%)-187.5064.89-381.1563.4552.96
   PAT Growth(%)-122.586.06-115.3055.7653.24
   EPS Growth(%)-129.10-127.171097.7164.4468.03
Financial Stability Ratios
   Total Debt/Equity(x)0.570.490.701.221.28
   Current Ratio(x)0.560.760.730.690.98
   Quick Ratio(x)0.370.520.470.480.70
   Interest Cover(x)-1.07-0.37-1.28-0.24-0.68
   Total Debt/Mcap(x)0.850.490.511.680.69